Non-invasive peripheral focused ultrasound neuromodulation of the celiac plexus ameliorates symptoms in a rat model of inflammatory bowel disease.
Crohn's disease
IBD
bioelectric medicine
celiac plexus
dextran sulfate sodium
medical device
peripheral ganglion
superior mesenteric plexus
ulcerative colitis
Journal
Experimental physiology
ISSN: 1469-445X
Titre abrégé: Exp Physiol
Pays: England
ID NLM: 9002940
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
15
06
2020
accepted:
26
01
2021
pubmed:
30
1
2021
medline:
1
4
2022
entrez:
29
1
2021
Statut:
ppublish
Résumé
What is the central question of this study? Does peripheral non-invasive focused ultrasound targeted to the celiac plexus improve inflammatory bowel disease? What is the main finding and its importance? Peripheral non-invasive focused ultrasound targeted to the celiac plexus in a rat model of ulcerative colitis improved stool consistency and reduced stool bloodiness, which coincided with a longer and healthier colon than in animals without focused ultrasound treatment. The findings suggest that this novel neuromodulatory technology could serve as a plausible therapeutic approach for improving symptoms of inflammatory bowel disease. Individuals suffering from inflammatory bowel disease (IBD) experience significantly diminished quality of life. Here, we aim to stimulate the celiac plexus with non-invasive peripheral focused ultrasound (FUS) to modulate the enteric cholinergic anti-inflammatory pathway. This approach may have clinical utility as an efficacious IBD treatment given the non-invasive and targeted nature of this therapy. We employed the dextran sodium sulfate (DSS) model of colitis, administering lower (5%) and higher (7%) doses to rats in drinking water. FUS on the celiac plexus administered twice a day for 12 consecutive days to rats with severe IBD improved stool consistency scores from 2.2 ± 1 to 1.0 ± 0.0 with peak efficacy on day 5 and maximum reduction in gross bleeding scores from 1.8 ± 0.8 to 0.8 ± 0.8 on day 6. Similar improvements were seen in animals in the low dose DSS group, who received FUS only once daily for 12 days. Moreover, animals in the high dose DSS group receiving FUS twice daily maintained colon length (17.7 ± 2.5 cm), while rats drinking DSS without FUS exhibited marked damage and shortening of the colon (13.8 ± 0.6 cm) as expected. Inflammatory cytokines such as interleukin (IL)-1β, IL-6, IL-17, tumour necrosis factor-α and interferon-γ were reduced with DSS but coincided with control levels after FUS, which is plausibly due to a loss of colon crypts in the former and healthier crypts in the latter. Lastly, overall, these results suggest non-invasive FUS of peripheral ganglion can deliver precision therapy to improve IBD symptomology.
Substances chimiques
Cytokines
0
Dextran Sulfate
9042-14-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1038-1060Informations de copyright
© 2021 The Authors. Experimental Physiology © 2021 The Physiological Society.
Références
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003). Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. New England Journal of Medicine 348, 601-608.
Bassi, G. S., Dias, D. P. M., Franchin, M., Talbot, J., Reis, D. G., Menezes, G. B., Castania, J. A., Garcia-Cairasco, N., Resstel, L. B. M., Salgado, H. C., Cunha, F. Q., Cunha, T. M., Ulloa, L., & Kanashiro, A. (2017). Modulation of experimental arthritis by vagal sensory and central brain stimulation. Brain, Behavior, and Immunity 64, 330-343.
Berthoud, H. R. (2008). The vagus nerve, food intake and obesity. Regulatory Peptides 149, 15-25.
Bewtra, M., Su, C., & Lewis, J. D. (2007). Trends in hospitalization rates for inflammatory bowel disease in the United States. Clinical Gastroenterology and Hepatology 5, 597-601.
Billioud, V., Ford, A. C., Tedesco, E. D., Colombel, J. F., Roblin, X., & Peyrin-Biroulet, L. (2013). Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis. Journal of Crohn's and Colitis 7, 853-867.
Bonaz, B., Sinniger, V., Hoffmann, D., Clarencon, D., Mathieu, N., Dantzer, C., Vercueil, L., Picq, C., Trocme, C., Faure, P., Cracowski, J. L., & Pellissier, S. (2016). Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. Neurogastroenterology & Motility 28, 948-953.
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462.
Bronte, V., & Pittet, M. J. (2013). The spleen in local and systemic regulation of immunity. Immunity 39, 806-818.
Browning, K. N., Verheijden, S., & Boeckxstaens, G. E. (2017). The vagus nerve in appetite regulation, mood, and intestinal inflammation. Gastroenterology 152, 730-744.
Cailotto, C., Gomez-Pinilla, P. J., Costes, L. M., van der Vliet, J., Di Giovangiulio, M., Nemethova, A., Matteoli, G., & Boeckxstaens, G. E. (2014). Neuro-anatomical evidence indicating indirect modulation of macrophages by vagal efferents in the intestine but not in the spleen. PLoS One 9, e87785.
Chassaing, B., Aitken, J. D., Malleshappa, M., & Vijay-Kumar, M. (2014). Dextran sulfate sodium (DSS)-induced colitis in mice. Current Protocols in Immunology 104, 15.25.11-15.25.14.
Chen, W., Zhang, J., Li, C., Pan, Q., Wu, J., Fan, L., Chen, C., Huang, X., Teng, F., & Zhu, J. (2019). Is dextran sulfate sodium a good inducer of acute experimental enteritis? International Journal of Immunopathology and Pharmacology 33, 2058738419843367.
Cotero, V., Fan, Y., Tsaava, T., Kressel, A. M., Hancu, I., Fitzgerald, P., Wallace, K., Kaanumalle, S., Graf, J., Rigby, W., Kao, T.-J., Roberts, J., Bhushan, C., Joel, S., Coleman, T. R., Zanos, S., Tracey, K. J., Ashe, J., Chavan, S. S., & Puleo, C. (2019). Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation. Nature Communications 10, 952.
Dahlhamer, J. M., Zammitti, E. P., Ward, B. W., Wheaton, A. G., & Croft, J. B. (2016). Prevalence of inflammatory bowel disease among adults aged ≥18 Years - United States, 2015. Morbidity and Mortality Weekly Report 65, 1166-1169.
de Lartigue, G., & Diepenbroek, C. (2016). Novel developments in vagal afferent nutrient sensing and its role in energy homeostasis. Current Opinion in Pharmacology 31, 38-43.
de Mattos, B. R. R., Garcia, M. P. G., Nogueira, J. B., Paiatto, L. N., Albuquerque, C. G., Souza, C. L., Fernandes, L. G. R., da Silva Cunha Tamashiro, W. M., & Simioni, P. U. (2015). Inflammatory bowel disease: an overview of immune mechanisms and biological treatments. Mediators of Inflammation 2015, 493012.
Dharmani, P., Leung, P., & Chadee, K. (2011). Tumor necrosis factor-α and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphate-induced colitis. PLoS One 6, e25058-e25058.
Eichele, D. D., & Kharbanda, K. K. (2017). Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World Journal of Gastroenterology 23, 6016-6029.
Gabrysová, L., Nicolson, K. S., Streeter, H. B., Verhagen, J., Sabatos-Peyton, C. A., Morgan, D. J., & Wraith, D. C. (2009). Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. The Journal of Experimental Medicine 206, 1755-1767.
Gigliotti, J. C., Huang, L., Ye, H., Bajwa, A., Chattrabhuti, K., Lee, S., Klibanov, A. L., Kalantari, K., Rosin, D. L., & Okusa, M. D. (2013). Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. Journal of the American Society of Nephrology 24, 1451-1460.
Goverse, G., Stakenborg, M., & Matteoli, G. (2016). The intestinal cholinergic anti-inflammatory pathway. Journal of Physiology 594, 5771-5780.
Grundy, D. (2015a). Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology. Journal of Physiology 593, 2547-2549.
Grundy, D. (2015b). Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology. Experimental Physiology 100, 755-758.
Guo, J., Jin, H., Shi, Z., Yin, J., Pasricha, T., & Chen, J. D. Z. (2019). Sacral nerve stimulation improves colonic inflammation mediated by autonomic-inflammatory cytokine mechanism in rats. Neurogastroenterology & Motility 31, e13676.
Ji, H., Rabbi, M. F., Labis, B., Pavlov, V. A., Tracey, K. J., & Ghia, J. E. (2014). Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis. Mucosal Immunology 7, 335-347.
Kiesler, P., Fuss, I. J., & Strober, W. (2015). Experimental models of inflammatory bowel diseases. Cellular and Molecular Gastroenterology and Hepatology 1, 154-170.
Kim, D. H., & Cheon, J. H. (2017). Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. Immune Networks 17, 25-40.
Kim, J. J., Shajib, M. S., Manocha, M. M., & Khan, W. I. (2012). Investigating intestinal inflammation in DSS-induced model of IBD. Journal of Visualized Experiments, 3678.
Komegae, E. N., Farmer, D. G. S., Brooks, V. L., McKinley, M. J., McAllen, R. M., & Martelli, D. (2018). Vagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway. Brain, Behavior, and Immunity 73, 441-449.
Lori, A., Perrotta, M., Lembo, G., & Carnevale, D. (2017). The spleen: a hub connecting nervous and immune systems in cardiovascular and metabolic diseases. International Journal of Molecular Sciences 18, 1216.
Maria-Ferreira, D., Nascimento, A. M., Cipriani, T. R., Santana-Filho, A. P., da Silva Watanabe, P., de Mello Gonçales Sant Ana, D., Luciano, F. B., Bocate, K. C. P., van den Wijngaard, R. M., de Paula Werner, M. F., & Baggio, C. H. (2018). Rhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells. Scientific Reports 8, 12261-12261.
Martelli, D., Farmer, D. G. S., McKinley, M. J., Yao, S. T., & McAllen, R. M. (2019). Anti-inflammatory reflex action of splanchnic sympathetic nerves is distributed across abdominal organs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 316, R235-R242.
Martelli, D., McKinley, M. J., & McAllen, R. M. (2014). The cholinergic anti-inflammatory pathway: a critical review. Autonomic Neuroscience 182, 65-69.
McCorry, L. K. (2007). Physiology of the autonomic nervous system. American Journal of Pharmaceutical Education 71, 78-78.
Mehta, F. (2016). Report: economic implications of inflammatory bowel disease and its management. American Journal of Managed Care 22, s51-s60.
Meregnani, J., Clarencon, D., Vivier, M., Peinnequin, A., Mouret, C., Sinniger, V., Picq, C., Job, A., Canini, F., Jacquier-Sarlin, M., & Bonaz, B. (2011). Anti-inflammatory effect of vagus nerve stimulation in a rat model of inflammatory bowel disease. Autonomic Neuroscience 160, 82-89.
Meyers, E. E., Kronemberger, A., Lira, V., Rahmouni, K., & Stauss, H. M. (2016). Contrasting effects of afferent and efferent vagal nerve stimulation on insulin secretion and blood glucose regulation. Physiological Reports 4, e12718.
M'Koma, A. E. (2013). Inflammatory bowel disease: an expanding global health problem. Clinical Medicine Insights: Gastroenterology 6, 33-47.
Mohan, N., Edwards, E. T., Cupps, T. R., Oliverio, P. J., Sandberg, G., Crayton, H., Richert, J. R., & Siegel, J. N. (2001). Demyelination occurring during anti-tumor necrosis factor α therapy for inflammatory arthritides. Arthritis & Rheumatology 44, 2862-2869.
Murray, K., & Reardon, C. (2018). The cholinergic anti-inflammatory pathway revisited. Neurogastroenterology & Motility e13288, 30.
Narouze, S. N. (ed) (2018). Atlas of Ultrasound-guided Procedures in Interventional Pain Management. Springer-Verlag, New York.
Nielsen, O. H., & Ainsworth, M. A. (2013). Tumor necrosis factor inhibitors for inflammatory bowel disease. New England Journal of Medicine 369, 754-762.
Nunes, N. S., Chandran, P., Sundby, M., Visioli, F., da Costa Goncalves, F., Burks, S. R., Paz, A. H., & Frank, J. A. (2019). Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway. EBioMedicine 45, 495-510.
Park, Y. H., Kim, N., Shim, Y. K., Choi, Y. J., Nam, R. H., Choi, Y. J., Ham, M. H., Suh, J. H., Lee, S. M., Lee, C. M., Yoon, H., Lee, H. S., & Lee, D. H. (2015). Adequate dextran sodium sulfate-induced colitis model in mice and effective outcome measurement method. Journal of Cancer Prevention 20, 260-267.
Pavlov, V. A., & Tracey, K. J. (2012). The vagus nerve and the inflammatory reflex-linking immunity and metabolism. Nat Rev Endocrinol 8, 743-754.
Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G., & Tracey, K. J. (2003). The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Molecular Medicine 9, 125-134.
Payne, C. M., Burke, L. P., Cavanagh, B., O'Toole, D., Cryan, S. A., & Kelly, H. M. (2019a). Evaluation of the immunomodulatory effects of all-trans retinoic acid solid lipid nanoparticles and human mesenchymal stem cells in an A549 epithelial cell line model. Pharmaceutical Research 36, 50.
Payne, S. C., Furness, J. B., Burns, O., Sedo, A., Hyakumura, T., Shepherd, R. K., & Fallon, J. B. (2019b). Anti-inflammatory effects of abdominal vagus nerve stimulation on experimental intestinal inflammation. Frontiers in Neuroscience 13, 418-418.
Payne, S. C., Furness, J. B., Burns, O., Sedo, A., Hyakumura, T., Shepherd, R. K., & Fallon, J. B. (2019c). Anti-inflammatory effects of abdominal vagus nerve stimulation on experimental intestinal inflammation. Frontiers in Neuroscience 13, 418.
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994). Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553-562.
Puleo, C., & Cotero, V. (2020). Noninvasive neuromodulation of peripheral nerve pathways using ultrasound and its current therapeutic implications. Cold Spring Harbor Perspectives in Medicine 10, a034215.
Rosas-Ballina, M., Olofsson, P. S., Ochani, M., Valdes-Ferrer, S. I., Levine, Y. A., Reardon, C., Tusche, M. W., Pavlov, V. A., Andersson, U., Chavan, S., Mak, T. W., & Tracey, K. J. (2011). Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98-101.
Sairenji, T., Collins, K. L., & Evans, D. V. (2017). An update on inflammatory bowel disease. Primary Care 44, 673-692.
Sanchez-Munoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. -. K. (2008). Role of cytokines in inflammatory bowel disease. World journal of Gastroenterology 14, 4280-4288.
Seror, R., Richez, C., Sordet, C., Rist, S., Gossec, L., Direz, G., Houvenagel, E., Berthelot, J. M., Pagnoux, C., Dernis, E., Melac-Ducamp, S., Bouvard, B., Asquier, C., Martin, A., Puechal, X., Mariette, X., & Club Rhumatismes et Inflammation Section of the SFR (2013). Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology 52, 868-874.
Sokol, H., Seksik, P., & Cosnes, J. (2014). Complications and surgery in the inflammatory bowel diseases biological era. Current Opinion in Gastroenterology 30, 378-384.
Sun, P., Zhou, K., Wang, S., Li, P., Chen, S., Lin, G., Zhao, Y., & Wang, T. (2013). Involvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation. PLoS One 8, e69424.
Sundman, E., & Olofsson, P. S. (2014). Neural control of the immune system. Advances in Physiology Education 38, 135-139.
Takagawa, T., Kitani, A., Fuss, I., Levine, B., Brant, S. R., Peter, I., Tajima, M., Nakamura, S., & Strober, W. (2018). An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis. Science Translational Medicine 10, eaan8162.
Walrath, T., Malizia, R. A., Zhu, X., Sharp, S. P., D'Souza, S. S., Lopez-Soler, R., Parr, B., Kartchner, B., Lee, E. C., Stain, S. C., Iwakura, Y., & O'Connor W. Jr. (2020). IFN-gamma and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon. American Journal of Physiology. Gastrointestinal and Liver Physiology 318, G479-G489.
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., Al-Abed, Y., Czura, C. J., & Tracey, K. J. (2003). Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384-388.
Willemze, R. A., Welting, O., van Hamersveld, H. P., Meijer, S. L., Folgering, J. H. A., Darwinkel, H., Witherington, J., Sridhar, A., Vervoordeldonk, M. J., Seppen, J., & de Jonge, W. J. (2018). Neuronal control of experimental colitis occurs via sympathetic intestinal innervation. Neurogastroenterology & Motility e13163, 30.
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017). Chemically induced mouse models of acute and chronic intestinal inflammation. Nature Protocols 12, 1295-1309.